Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy
Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy
复制标题
DOI:
10.1001/archneur.63.8.1144
复制
发表时间:
2006-08-01
影响因子:
--
通讯作者:
Johnston, Wendy S.
中科院分区:
文献类型:
--
作者:
Kalra, Sanjay;Hanstock, Christopher C.;Johnston, Wendy S.
Background: Clinical assessment is insensitive to the degree of cerebral involvement in amyotrophic lateral sclerosis (ALS). Regional brain concentrations N-acetylaspartylglutamate (NAA) plus myo-inositol (Ins), as measured by magnetic resonance spectroscopy, are respectively decreased and increased, suggesting that these compounds may provide a biomarker of the degree of cerebral involvement in ALS.Objective: To test the hypothesis that the NAA/Ins ratio may provide an index of cerebral involvement in patients with ALS.Design: High-field (3.0-T) magnetic resonance spectroscopy was performed to determine the NAA/creatine plus phosphocreatine (NAA/Cr), NAA/choline (NAA/Cho), Ins/Cr, and NAA/Ins ratios in the motor cortex.Participants: Seventeen patients with ALS and 15 healthy control subjects were studied.Results: In patients with ALS, the greatest abnormality was a 22% decrease in NAA/Ins (71% sensitivity and 93% specificity, P=.001); Ins/Cr was increased 18% (88% sensitivity and 53% specificity, P=.04), NAA/Cr was decreased 10% (88% sensitivity and 47% specificity, P=.04), and NAA/Cho was decreased 14% (53% sensitivity and 87% specificity, P=.047). Correlation of the ALS Functional Rating Scale with NAA/Ins approached statistical significance (R=0.43, P=.07).Conclusion: The NAA/Ins ratio may provide a meaningful biomarker in ALS given its optimal sensitivity and specificity profile.